Optiver Holding’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Optiver Holding's NVO Position: Q1 2026 in Review
Optiver Holding sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 983,717 shares — an estimated $46.6M sold.
Optiver Holding first reported a position in NVO in Q3 2021 and held it in 14 quarters. The position peaked at $50.1M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Optiver Holding reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Optiver Holding sold 983,717 Novo Nordisk shares in Q1 2026, an estimated $46.6M.
- Optiver Holding first reported a position in Novo Nordisk in Q3 2021 and held it in 14 quarters.
- Optiver Holding's Novo Nordisk position peaked at $50.1M in Q4 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.